Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature

Since their license in 2008, studies on thrombopoietin receptor agonists (TPO-RAs) are proceeding at a fast pace. Their favorable efficacy and safety profile makes them good candidates for the management of thrombocytopenia in different settings, even beyond their current indications. In the last 10...

Full description

Bibliographic Details
Main Authors: Marco Capecchi, Fabio Serpenti, Juri Giannotta, Loredana Pettine, Gianluigi Reda, Ida Martinelli, Andrea Artoni, Wilma Barcellini, Bruno Fattizzo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
thrombopoietin receptor agonist
eltrombopag
romiplostim
myelodysplastic syndromes
transplant
lymphoproliferative syndromes
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.680411/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.680411/full

Similar Items